Publications

Liquid biopsy for the diagnosis of EBV-positive Burkitt's lymphoma in endemic areas.

Chamba C. et al, (2026), Nat Med

Is liquid biopsy a cost-effective method to diagnose Burkitt Lymphoma in children and young adults? A health economic evaluation in Tanzania.

Jiang J. et al, (2026), BMC Med, 24

Optimising antibiotic “review and revise” in acute/general medical inpatients: the Antibiotic Review Kit in Hospitals (ARK-Hospital) research programme including a stepped-wedge cluster-randomised trial

Llewelyn MJ. et al, (2025), NIHR Journals Library

Diagnosing Burkitt Lymphoma in Sub-Saharan Africa by Sequencing of Circulating Tumor DNA: A Comparative Microcosting Study.

Morrell L. et al, (2025), Value Health Reg Issues, 48

Rituximab for children with EBV-positive Burkitt lymphoma in East Africa.

Mawalla WF. et al, (2025), Blood Adv, 9, 2393 - 2401

Targeted Next-Generation Sequencing of Cell-Free DNA to Detect MYC-Immunoglobulin Translocation and Epstein-Barr Virus DNA in Plasma of Burkitt Lymphoma Patients in East Africa.

Chamba C. et al, (2025), JCO Glob Oncol, 11

Clinical Validation of Liquid Biopsy for Faster Molecular Diagnosis of EBV-Positive Burkitt Lymphoma

Chamba C. et al, (2025)

THE RISE OF OPTIMIZATION IN NICE GUIDANCE: A TWO-DECADE REVIEW WITH A FOCUS ON PREVENTION Rachel EA Barr-Keenan, BDS (Hons), MFDS RCPSG (Glas)1

Barr-Keenan REA. and Morrell L., (2025), VALUE IN HEALTH, 28

"TELL ME A STORY": A RANDOMIZED STUDY COMPARING TABULATED AND NARRATIVE PRESENTATIONS OF A DISCRETE CHOICE EXPERIMENT

Morrell L. et al, (2025), VALUE IN HEALTH, 28

Using liquid biopsy in early lung cancer diagnosis: A systematic review of health economic analyses and budget impact analysis for the UK NHS

Kew E. et al, (2025), JOURNAL OF THORACIC ONCOLOGY, 20

THE RISE OF OPTIMIZATION IN NICE GUIDANCE: A TWO-DECADE REVIEW WITH A FOCUS ON PREVENTION

Barr-Keenan REA. and Morrell L., (2025), VALUE IN HEALTH, 28

How, why and when are delayed (back-up) antibiotic prescriptions used in primary care? A realist review integrating concepts of uncertainty in healthcare.

Mcleod M. et al, (2024), BMC Public Health, 24

Overcoming challenges in the economic evaluation of interventions to optimise antibiotic use.

Roope LSJ. et al, (2024), Commun Med (Lond), 4

We need to talk about values: a proposed framework for the articulation of normative reasoning in health technology assessment.

Charlton V. et al, (2024), Health Econ Policy Law, 19, 153 - 173

Treatment delays in children and young adults with lymphoma: a report from an East Africa lymphoma cohort study.

Mawalla WF. et al, (2023), Blood Adv, 7, 4962 - 4965

Search results (41)